LEARN MORE

Learn More About CCherbal

CCherbal: 
A proprietary herbal blend of chinese herbs:
Qing Dai(main ingredient)
Huang Qin
Mu Xiang
cc herbal for ulcerative colitis support health
Money Back Guarantee and Return Policy:
Your purchase of CCherbal is warranted by a money back guarantee. Any bottle of CCherbal that is unopened with the safety seal intact may be returned within 90 days of purchase for a refund. We are unable to accept or issue refunds for opened containers, or those with a damaged safety seal. All refunds MUST be approved prior to return and require an authorization number and original order invoice. Shipping and handling charges on returned or refused packages will not be refunded.
Processing Returns:
  1. Contact us for a Return Authorization Number. 
  2. Write down the Return Authorization Number on the original invoice. 
  3. Ensure that the return is mailed via Signature Confirmation - this is required to receive a refund. 

Return Address: 
CCherbal, LLC 
Suite 236 675 N Deis Drive
Fairfield, Ohio 45014
Dosing: 
Take 1 600mg CCherbal capsule in the morning, afternoon and before bed (3 capsules per day). Take capsules with a full glass of water.
cc herbal supplement panel

Published Articles about the ingredients in CCherbal

PubMeb - This is the first prospective study indicating that oral Qing-Dai is effective for inducing remission m patients with moderate UC activity and can be tolerated.
* "This is the first prospective study indicating that oral Qing-Dai is effective for inducing remission in patients with moderate UC activity and can be tolerated."
Read More
Qing Dai, which is used in Traditional Chinese Medicine (TCM) to treat ulcerative colitis. In one small study, published a few years ago, six of the seven patients with ulcerative colitis were able to stop using prescription meds completely.
* "Qing Dai, which is used in Traditional Chinese Medicine (TCM) to treat ulcerative colitis. In one small study, published a few years ago, six of the seven patients with ulcerative colitis were able to stop using prescription meds completely."
Read More
Therapeutic efficacy of the Qing Di in patients with intractable ulcerative colitis.
"Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis."
Read More
Therapeutic efficacy of the Qing D patients with intractable ulcerative colitis.
* "Therapeutic efficacy of the Qing Dai patients with intractable ulcerative colitis."
Read More
Qing Dai showed significant clinical and endoscopic efficacy in patients who failed to respond to conventional medications.
* "Qing Dai showed significant clinical and endoscopic efficacy in patients who failed to respond to conventional medications."
Read More

Studies - Read what the scientific community has to say

1. Anti-inflammatory effects of the extract of indigo naturalis (Qing Dai) in human neutrophils. J Ethnopharmacol 2009, Lin YK, Leu YL, Huang TH, Wu YH, Chung PJ, Su Pang JH, Hwang TL

2. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study. J Ethnopharmacol 2012, Gong Y, Zha Q, Li L, Liu Y, Yang B, Liu L, Lu A, Lin Y, Jiang M

3. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis. World J Gastroenterol 2013, Suzuki H, Kaneko T, Mizokami Y, Narasaka T, Endo S, Matsui H, Yanaka A, Hirayama A, Hyodo I

4. Qing Dai, a traditional Chinese medicine for the treatment of chronic hemorrhagic proctitis. J Clin Oncol 2009, Yuan G, Ke Q, Su X, Yang J, Xu X

5. Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: a meta-analysis. World J Gastroenterol 2013; Rahimi R, Nikfar S, Abdollahi M

6. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther 2013; Ng SC, Lam YT, Tsoi KK, Chan FK, Sung JJ, Wu JC

7. Ulcerative Colitis Treatment. Lancet 2012; Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ:

8. Evidence-based practice guideline of Chinese herbal medicine. Eur J Integr Med 2014, Zhou D, Chen W, Li X, Deng B, Xu W, Qu J, Zhang G, Zhang C, Sun L, Jiang C, Xu J, Li P, Chen J, Duan Y, Yang Z, Bai, Y, Liu W, Qu X, Wang P, Liu J

9. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007; D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR

10. Toronto Ulcerative Colitis Consensus Group: Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus. Gastroenterology 2015, Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, Panaccione R, Steinhart AH, Tse F, Feagan B

11. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S

12. Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis. Inflammatory Bowel Disease 2012; Ogata H, Kato J, Hirai F, Hida N, Matsui T, Matsumoto T, Koyanagi K, Hibi T

13. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002; Jiang XL, Cui HF:

14. Chinese Cooperative Group for the Study on IBD; Chinese Society of Gastroenterology, Ouyang Q, Hu PJ, Qian JM, Zheng JJ, Hu RW: Consensus on the management of inflammatory bowel disease in China in 2007. J Dig Dis 2008

15. Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis. J Gastroenterol Hepatol 2012, Fukunaga K, Ohda Y, Hida N, Iimuro M, Yokoyama Y, Kamikozuru K, Nagase K, Nakamura S, Miwa H, Matsumoto T

16. Kui jie qing in the treatment of chronic non-specific ulcerative colitis. Traditional Chinese Medicinr 1997, Wang B, Ren S, Feng W, Zhong Z, Qin C:
Share by: